Cytoxan

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Stem Cell Transplantation in Crohn's Disease

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)

3rd Generation GD-2 Chimeric Antigen Receptor and ICaspase Suicide Safety Switch, Neuroblastoma, GRAIN

Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Umbilical Cord Blood Transplant for Congenital Pediatric Disorders

A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma

Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma

Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies